Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

1.60
-0.0800-4.76%
Post-market: 1.600.00000.00%16:04 EDT
Volume:441.94K
Turnover:718.99K
Market Cap:9.26M
PE:0.74
High:1.71
Open:1.58
Low:1.55
Close:1.68
Loading ...
Mar 25, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 23, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2021

Major Issues Report

8-K - Current report
Mar 04, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 08, 2021

Major Issues Report

8-K - Current report
Dec 30, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 16, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Major Issues Report

8-K - Current report
Oct 01, 2020

Major Issues Report

8-K - Current report